HLA class II histocompatibility antigen, DRB1-7 beta chain, transcript variant X1: A Drug Target / Disease Biomarker

Target Name: HLA class II histocompatibility antigen, DRB1-7 beta chain, transcript variant X1

NCBI ID: G105369230

HLA class II histocompatibility antigen, DRB1-7 beta chain, transcript variant X1

HLA class II histocompatibility antigen, DRB1-7 beta chain, transcript variant X1: A Drug Target / Disease Biomarker

HLA class II histocompatibility antigen, DRB1-7 beta chain, transcript variant X1 is a protein that is expressed in the major histocompatibility complex (MHC) class II molecules. It is a key component of the immune system and plays a crucial role in the regulation of T cell development and function. DRB1-7 beta chain, transcript variant X1 is a specific variant of the DRB1 gene that is located on the X chromosome.

The DRB1 gene is a member of the major histocompatibility complex (MHC) class II gene family. These genes encode antigens that are recognized by T cells as foreign and activate an immune response. The MHC class II system is one of the four main systems used by the immune system to recognize and respond to foreign antigens.

DRB1-7 beta chain is a transmembrane protein that is expressed in various tissues and cells of the body. It is a key component of the immune system and plays a crucial role in the regulation of T cell development and function. The DRB1-7 gene is located on the X chromosome and has four exons.

Transcript variant X1 is a specific variant of the DRB1 gene that is located on the X chromosome. It is a single-exon gene that encodes a protein with 114 amino acid residues. The protein has a unique structure and is expressed in various tissues and cells of the body.

HLA class II histocompatibility antigen, DRB1-7 beta chain, transcript variant X1 is a protein that is expressed in the immune system and plays a crucial role in the regulation of T cell development and function. It is a potential drug target or biomarker and may be used in the development of new therapies for various diseases.

Protein Name: HLA Class II Histocompatibility Antigen, DRB1-7 Beta Chain, Transcript Variant X1

The "HLA class II histocompatibility antigen, DRB1-7 beta chain, transcript variant X1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HLA class II histocompatibility antigen, DRB1-7 beta chain, transcript variant X1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets